Mission
Norgine is leading and will continue to lead the development of the European Specialty Pharmaceutical sector in order to develop, source, manufacture and market innovative medicines for the benefit of patients, employees and other stakeholders.
Our mission encompasses three core elements.
To be the European partner of choice by ensuring that Norgine continuously operates in all our markets at the highest standard of quality expected of the pharmaceutical industry and by ensuring that we always honour our ethical obligations towards patients as well as customers, physicians, corporate partners and other stakeholders.
Having built a unique pharmaceutical infrastructure across Europe, Norgine must leverage this investment by licensing in and acquiring new products to help improve patient care and sustain our sales growth.
Norgine has a pipeline of R&D projects, which we seek to drive forward to create innovative products which we can sell through our European infrastructure and, where we own global rights, license out to partners in other major markets.